 |
Thorax PodcastAuthor: BMJ Group
The Thorax podcast offers the latest insights in respiratory medicine. Each episode features in-depth interviews with renowned authors and leading experts in the field, delving into the latest respiratory research and treatments.Thorax, an esteemed international journal from the BMJ Group and the British Thoracic Society (BTS), is dedicated to publishing research and reviews in respiratory medicine to improve clinical practice. Stay ahead in your field by tuning into our expert discussions and accessing cutting-edge content.Elevate your understanding of respiratory medicine with Thorax - thorax.bmj.com - and its podcast. Language: en-gb Genres: Health & Fitness, Medicine Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
The risks of inhaled corticosteroid withdrawal in COPD treatment
Episode 86
Monday, 24 August, 2026
Previous trials on triple therapy inhaler use (ETHOS and IMPACT) were understood to show a reduction in mortality in COPD patients. However, a reanalysis published in Thorax shows that this benefit may have been misattributed. Host Dr. Kate Diomede is joined by the paper's authors, pharmacist Kari Leung¹ and physician Prof. Aroon Hingorani², both members of the North Central London Joint Formulary committee. Read the paper: Inhaled corticosteroid withdrawal and mortality rate in trials of triple therapy inhalers for COPD Further reading: Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial 1. UCL Hospitals NHS Foundation Trust, London, UK 2. University College London, London, UK Please engage in the conversation through the social media channels (Twitter - @ThoraxBMJ; Facebook - Thorax.BMJ) and subscribe on your preferred platform, to get the latest episodes directly on your device each month. We would love to hear your thoughts on the podcast, you can leave a review on Apple Podcasts or Spotify.
